東華大學圖書館 |

Exscalate4CoV = high-performance computing for COVID drug discovery /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Exscalate4CoV/ edited by Silvano Coletti, Gabriella Bernardi.
其他題名:	high-performance computing for COVID drug discovery /
其他作者:	Coletti, Silvano.
出版者:	Cham :Springer International Publishing : : 2023.,
面頁冊數:	xvii, 86 p. :ill., digital ;24 cm.
內容註:	Preface (Arieh Warshel) -- Acknowledgments -- How should this text be read -- Chapter 1 Introduction (Silvano Coletti, Marcello Allegretti) -- Chapter 2 A European Drug Discovery Platform: From In Silico to Experimental Validation (Gianluca Palermo, Daniela Iaconis, Philip Gribbon) -- Chapter 3 The Drug Repurposing Strategy in the Exscalate4CoV Project: Raloxifene Clinical Trials (Andrea Beccari, Lamberto Dionigi, Emanuele Nicastri, Candida Manelfi, Elizabeth Gavioli) -- Chapter 4 The High-Performance Computing Resources for the Exscalate4CoV Project (Andrew Emerson, Federico Ficarelli, Gianluca Palermo, Freancesco Frigerio) -- Chapter 5 The Impact of the Scientific Metaverse on the Biotech Industry: How Virtual Reality Helped Researchers Fight Back Against COVID-19 (Carmine Talarico, Edgardo Leija) -- Chapter 6 From Genome to Variant Interpretation Through 3D Protein Structures (Janani Durairaj, Leila Tamara Alexander, Gabriel Studer, Gerardo Tauriello, Ingrid Guarnetti Prandi, Rosalba Lepore, Giovanni Chillemi, Torsten Schwede) -- Chapter 7 The Role of Structural Biology Task Force: Validation of the Binding Mode of Repurposed Drugs Against SARS-CoV-2 Protein Targets (Paola Storici, Elisa Costanzi, Stefano Morasso) -- Chapter 8 Drug Discovery and Big Data: From Research to the Community (Luca Barbanotti, Marta Cicchetti, Gaetano Varriale) -- Chapter 9 Exploiting Drug Discovery Research for Educational Purposes (Giuliana Catara, Cristina Rigutto) -- Chapter 10 Beyond the Exscalate4CoV Project: LIGATE and REMEDI4ALL Projects (Carmine Talarico, Davide Graziani, Andrea R. Beccari) -- Conclusion (Thomas Skordas)
Contained By:	Springer Nature eBook
標題:	Drugs - Design -
電子資源:	https://doi.org/10.1007/978-3-031-30691-4
ISBN:	9783031306914

Exscalate4CoV = high-performance computing for COVID drug discovery /
Exscalate4CoVhigh-performance computing for COVID drug discovery /[electronic resource] :edited by Silvano Coletti, Gabriella Bernardi. - Cham :Springer International Publishing :2023. - xvii, 86 p. :ill., digital ;24 cm. - SpringerBriefs in applied sciences and technology,2191-5318. - SpringerBriefs in applied sciences and technology..

Preface (Arieh Warshel) -- Acknowledgments -- How should this text be read -- Chapter 1 Introduction (Silvano Coletti, Marcello Allegretti) -- Chapter 2 A European Drug Discovery Platform: From In Silico to Experimental Validation (Gianluca Palermo, Daniela Iaconis, Philip Gribbon) -- Chapter 3 The Drug Repurposing Strategy in the Exscalate4CoV Project: Raloxifene Clinical Trials (Andrea Beccari, Lamberto Dionigi, Emanuele Nicastri, Candida Manelfi, Elizabeth Gavioli) -- Chapter 4 The High-Performance Computing Resources for the Exscalate4CoV Project (Andrew Emerson, Federico Ficarelli, Gianluca Palermo, Freancesco Frigerio) -- Chapter 5 The Impact of the Scientific Metaverse on the Biotech Industry: How Virtual Reality Helped Researchers Fight Back Against COVID-19 (Carmine Talarico, Edgardo Leija) -- Chapter 6 From Genome to Variant Interpretation Through 3D Protein Structures (Janani Durairaj, Leila Tamara Alexander, Gabriel Studer, Gerardo Tauriello, Ingrid Guarnetti Prandi, Rosalba Lepore, Giovanni Chillemi, Torsten Schwede) -- Chapter 7 The Role of Structural Biology Task Force: Validation of the Binding Mode of Repurposed Drugs Against SARS-CoV-2 Protein Targets (Paola Storici, Elisa Costanzi, Stefano Morasso) -- Chapter 8 Drug Discovery and Big Data: From Research to the Community (Luca Barbanotti, Marta Cicchetti, Gaetano Varriale) -- Chapter 9 Exploiting Drug Discovery Research for Educational Purposes (Giuliana Catara, Cristina Rigutto) -- Chapter 10 Beyond the Exscalate4CoV Project: LIGATE and REMEDI4ALL Projects (Carmine Talarico, Davide Graziani, Andrea R. Beccari) -- Conclusion (Thomas Skordas)

This book highlights the different aspects of the research project "E4C Horizon 2020 European Project" aimed at fighting the coronavirus by combining the best supercomputing resources and artificial intelligence with state-of-the-art experimental facilities up through clinical validation. Coronavirus disease has become an important public issue across the globe since December 2019. There is an urgent need to develop potent anti-COVID-19 agents for the prevention of the outbreak and stop viral infections. To this aim, a public-private consortium composed by European and national infrastructures, center of excellence, universities, and a pharmaceutical company started the E4C Horizon 2020 European Project: Its core idea was to use the EXaSCale smArt pLatform Against paThogEns (EXSCALATE) supercomputing platform for a process known as "drug repurposing", namely to identify the most promising safe in man drugs for immediate treatment of the already infected population and then novel pan-coronavirus inhibitors to address future emergencies. This ambitious goal exploited a "chemical library" of 500 billion molecules, thanks to a processing capacity of more than 3 million molecules per second, made available by the computing power of the EXSCALATE platform.

ISBN: 9783031306914

Standard No.: 10.1007/978-3-031-30691-4doiSubjects--Topical Terms:

752557
Drugs
--Design

LC Class. No.: RS420

Dewey Class. No.: 615.1900285411

Exscalate4CoV = high-performance computing for COVID drug discovery /
LDR:03986nmm a2200337 a 4500 001 2317556
003 DE-He213
005 20230502161816.0
006 m d
007 cr nn 008maaau
008 230902s2023 sz s 0 eng d
020 $a 9783031306914 $q (electronic bk.)
020 $a 9783031306907 $q (paper)
024 7 $a 10.1007/978-3-031-30691-4 $2 doi
035 $a 978-3-031-30691-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RS420
072 7 $a MQW $2 bicssc
072 7 $a TEC059000 $2 bisacsh
072 7 $a MQW $2 thema
082 0 4 $a 615.1900285411 $2 23
090 $a RS420 $b .E96 2023
245 0 0 $a Exscalate4CoV $h [electronic resource] : $b high-performance computing for COVID drug discovery / $c edited by Silvano Coletti, Gabriella Bernardi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xvii, 86 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in applied sciences and technology, $x 2191-5318
505 0 $a Preface (Arieh Warshel) -- Acknowledgments -- How should this text be read -- Chapter 1 Introduction (Silvano Coletti, Marcello Allegretti) -- Chapter 2 A European Drug Discovery Platform: From In Silico to Experimental Validation (Gianluca Palermo, Daniela Iaconis, Philip Gribbon) -- Chapter 3 The Drug Repurposing Strategy in the Exscalate4CoV Project: Raloxifene Clinical Trials (Andrea Beccari, Lamberto Dionigi, Emanuele Nicastri, Candida Manelfi, Elizabeth Gavioli) -- Chapter 4 The High-Performance Computing Resources for the Exscalate4CoV Project (Andrew Emerson, Federico Ficarelli, Gianluca Palermo, Freancesco Frigerio) -- Chapter 5 The Impact of the Scientific Metaverse on the Biotech Industry: How Virtual Reality Helped Researchers Fight Back Against COVID-19 (Carmine Talarico, Edgardo Leija) -- Chapter 6 From Genome to Variant Interpretation Through 3D Protein Structures (Janani Durairaj, Leila Tamara Alexander, Gabriel Studer, Gerardo Tauriello, Ingrid Guarnetti Prandi, Rosalba Lepore, Giovanni Chillemi, Torsten Schwede) -- Chapter 7 The Role of Structural Biology Task Force: Validation of the Binding Mode of Repurposed Drugs Against SARS-CoV-2 Protein Targets (Paola Storici, Elisa Costanzi, Stefano Morasso) -- Chapter 8 Drug Discovery and Big Data: From Research to the Community (Luca Barbanotti, Marta Cicchetti, Gaetano Varriale) -- Chapter 9 Exploiting Drug Discovery Research for Educational Purposes (Giuliana Catara, Cristina Rigutto) -- Chapter 10 Beyond the Exscalate4CoV Project: LIGATE and REMEDI4ALL Projects (Carmine Talarico, Davide Graziani, Andrea R. Beccari) -- Conclusion (Thomas Skordas)
520 $a This book highlights the different aspects of the research project "E4C Horizon 2020 European Project" aimed at fighting the coronavirus by combining the best supercomputing resources and artificial intelligence with state-of-the-art experimental facilities up through clinical validation. Coronavirus disease has become an important public issue across the globe since December 2019. There is an urgent need to develop potent anti-COVID-19 agents for the prevention of the outbreak and stop viral infections. To this aim, a public-private consortium composed by European and national infrastructures, center of excellence, universities, and a pharmaceutical company started the E4C Horizon 2020 European Project: Its core idea was to use the EXaSCale smArt pLatform Against paThogEns (EXSCALATE) supercomputing platform for a process known as "drug repurposing", namely to identify the most promising safe in man drugs for immediate treatment of the already infected population and then novel pan-coronavirus inhibitors to address future emergencies. This ambitious goal exploited a "chemical library" of 500 billion molecules, thanks to a processing capacity of more than 3 million molecules per second, made available by the computing power of the EXSCALATE platform.
650 0 $a Drugs $x Design $x Data processing. $3 752557
650 0 $a COVID-19 (Disease) $x Chemotherapy $x Research. $3 3631756
650 0 $a High performance computing. $3 591827
650 0 $a Artificial intelligence $x Medical applications. $3 900591
650 1 4 $a Biomedical Engineering and Bioengineering. $3 3381533
650 2 4 $a Health Informatics. $3 892928
650 2 4 $a Computer Modelling. $3 3538541
650 2 4 $a Molecular Biology. $3 600567
650 2 4 $a Computational Intelligence. $3 1001631
650 2 4 $a Proteins. $3 558769
700 1 $a Coletti, Silvano. $3 3631755
700 1 $a Bernardi, Gabriella. $3 2187079
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a SpringerBriefs in applied sciences and technology. $3 1565541
856 4 0 $u https://doi.org/10.1007/978-3-031-30691-4
950 $a Engineering (SpringerNature-11647)